Sophie Scott, PhD

Fellow of the Academy of Medical Sciences; Fellow of the British Academy; Wellcome Trust Senior Fellow at University College London; Head of Speech Communication Group at UCL’s Institute of Cognitive Neuroscience.

Professor Sophie Kerttu Scott is a British neuroscientist and Welcome Trust Senior Fellow at University College London, researching the neuroscience of voices, speech, and laughter. She is currently Deputy Director and Head of the Speech Communication Group at UCL’s Institute of Cognitive Neuroscience. Her work addresses the neurobiology of human vocal behaviour and vocal communication from sound to speech, covering the roles of streams of processing in the auditory cortex, hemispheric asymmetries and the interaction of speech processing with attentional and working memory factors. She pioneered the study of the human voice as a social signal, and has recently started to address the ways that non-verbal emotional expressions like laughter are used socially. Prof Scott is a member of the British Psychological Society, the Society for Neuroscience, the Cognitive Neuroscience Society, and the Experimental Psychology Society. She was also elected Fellow of the Academy of Sciences (FMedSci) in 2012. Scott is known for her public engagement work, including performing standup comedy. She was the 2017 Royal Institution Christmas Lecturer.

Patrik Brundin, PhD

Director of the Center for Neurodegenerative Science at Van Andel Institute in Michigan, USA

Professor Patrick Brundin is a renowned researcher of Parkinson’s disease and he’s currently director of the Center for Neurodegenerative Science at Van Andel Research Institute in Grand Rapids, Michigan, USA. He earned his PhD in 1988 and MD in 1992, both from Lund University, Sweden, and he has more than 350 publications on Parkinson’s disease and related topics. With over 40 years of experience studying this disease, his research focuses on pathogenic mechanisms of Parkinson’s and the development of new therapies that coud slow or stop disease progression ot that could repair affected brain circuits, translating experimental therapies into clinical trials. The swedish neuroscientist and his team described Lewy bodies in grafted dopamine neurons and suggested that a prion-like mechanism operates on Parkinson’s disease. He reported the effects of mutant α-synucleic on dopamine homeostasis, describing how their interaction might cause neurotoxity in Parkinson’s disease. Professor Patrik Brundin is a member of the World Parkinson Coalition Board of Directors and the The Michael J. Fox Foundation for Parkinson’s Research Executive Scientific Advisory Board. He also serves as co-editor-in-chief of the Journal of Parkinson’s disease and chair of the Linked Clinical Trials scientific committee. He was previously Professor of Neuroscience at Lund University in Sweden.